A meta-analysis in year 2009 summarized data from 13 prospective studies in various populations, and confirmed an inverse association between adiponectin levels and T2D risk5, since then, many more studies have been published with variability in the strength of the adiponectin-T2D association6–23. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.